Peptide Comparison
CapromorelinvsGHRP-6 (Growth Hormone Releasing Peptide-6)
An oral ghrelin agonist originally developed by Pfizer that stimulates growth hormone and appetite. FDA-approved for veterinary use (Entyce and Elura) and investigated in human trials for age-related muscle wasting and appetite support.
A synthetic hexapeptide that signals your pituitary to release growth hormone through a unique pathway, with emerging evidence of heart-protective benefits.
At a Glance
Quick
comparison
Dose Range
Capromorelin
3–30 mg
GHRP-6 (Growth Hormone Releasing Peptide-6)
100–300 mcg
Frequency
Capromorelin
Once daily
GHRP-6 (Growth Hormone Releasing Peptide-6)
Multiple times daily
Administration
Capromorelin
Oral (capsule or tablet)
GHRP-6 (Growth Hormone Releasing Peptide-6)
Subcutaneous injection
Cycle Length
Capromorelin
4-6 weeks
GHRP-6 (Growth Hormone Releasing Peptide-6)
8-12 weeks
Onset Speed
Capromorelin
Moderate (1-2 weeks)
GHRP-6 (Growth Hormone Releasing Peptide-6)
Moderate (1-2 weeks)
Evidence Level
Capromorelin
Moderate human trials (Phase 1-2)
GHRP-6 (Growth Hormone Releasing Peptide-6)
Limited human trials
Efficacy
Benefit
ratings
GH & IGF-1 Stimulation
Physical Function
Oral Convenience
Muscle Recovery and Growth
Cellular Health and Protection
Appetite and Nutrient Intake
Technical Data
Compound
specifications
Capromorelin
Molecular Formula
C28H35N5O4
Molecular Weight
505.6 g/mol
Half-Life
1-2.4 hours in humans
Bioavailability
Good oral bioavailability
CAS Number
193273-66-4
GHRP-6 (Growth Hormone Releasing Peptide-6)
Molecular Formula
C46H56N12O6
Molecular Weight
873.0 g/mol
Half-Life
~2.5 hours
Bioavailability
<1% oral, high subcutaneous
CAS Number
87616-84-0
Protocols
Dosing
tiers
Capromorelin
GHRP-6 (Growth Hormone Releasing Peptide-6)
Applications
Best
suited for
Capromorelin
Age-Related Muscle Wasting
Capromorelin showed significant improvements in physical function — including tandem walk and stair climb — in elderly adults, making it a strong candidate for combating sarcopenia.
Appetite Stimulation
As an FDA-approved veterinary appetite stimulant, capromorelin has extensive real-world evidence for boosting food intake and body weight in mammals.
Growth Hormone Research
One of the best-studied oral ghrelin agonists with human Phase 2 data, offering researchers a well-characterized tool for studying GH/IGF-1 pathways.
GHRP-6 (Growth Hormone Releasing Peptide-6)
Athletes and Serious Trainers
If you're hitting the gym hard and want better recovery and muscle growth, GHRP-6 amplifies your body's natural GH response. This is particularly valuable during intense training phases when you want to maximize adaptation and minimize soreness. The appetite stimulation also helps you consume the calories you need to grow.
Those Exploring Novel Peptide Protocols
GHRP-6 offers a unique mechanism through the ghrelin receptor, making it valuable for users who want to explore diverse GH-stimulation pathways. It works distinctly from GHRH-based approaches and pairs well with other GH secretagogues for synergistic effects.
Longevity and Metabolic Health Enthusiasts
Growth hormone plays roles in metabolic health, body composition, and potentially aging markers. GHRP-6's emerging research on cellular protection and antioxidant activation makes it interesting for those interested in broader health optimization beyond just muscle growth.
Safety Profile
Side
effects
Capromorelin
Common
- Appetite stimulation
- Fluid retention and weight gain
Uncommon
- Joint and muscle aches
- Fatigue or lethargy
- Peripheral edema (swelling)
Serious
- Hyperglycemia
GHRP-6 (Growth Hormone Releasing Peptide-6)
Common
- Increased Appetite
- Mild Joint or Muscle Discomfort
- Water Retention or Mild Swelling
Uncommon
- Sleep Disturbances
- Mild Dizziness or Lightheadedness
Serious
- Allergic Reaction
Research Status
Safety
& evidence
Capromorelin
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
FDA approved for this use
Safety Overview
Capromorelin was generally well-tolerated in Phase 2 human trials involving nearly 400 elderly participants. Most side effects were mild to moderate. Its FDA-approved veterinary use provides additional long-term safety data in mammalian species.
Contraindications
- xActive cancer or history of cancer (GH may stimulate growth)
- xUncontrolled diabetes or severe metabolic disorders
- xSevere liver or kidney disease
- xPregnancy and lactation
GHRP-6 (Growth Hormone Releasing Peptide-6)
Evidence Level
Limited human trials
FDA Status
Research compound
Safety Overview
GHRP-6 has a relatively long research history dating back to 1981, with human studies demonstrating its ability to stimulate GH release. The good news is that animal safety studies show excellent tolerability at high doses, and the side effects reported are generally mild and reversible. However, it's not FDA-approved, so use is based on research evidence rather than pharmaceutical oversight. Always purchase from reputable sources and consider medical consultation, especially if you have existing health conditions.
Contraindications
- xKnown allergy or sensitivity to any component of the peptide
- xActive cancer or history of cancer without medical clearance
- xSevere cardiovascular disease or uncontrolled hypertension
- xAcute critical illness or sepsis
Decision Guide
Which is
right for you?
Choose Capromorelin if...
- Stimulating growth hormone production in elderly adults
- Supporting appetite and weight gain in wasting conditions
- Improving muscle mass and physical performance
- Anti-aging and longevity optimization
Choose GHRP-6 (Growth Hormone Releasing Peptide-6) if...
- Building lean muscle mass and improving body composition
- Recovery from intense training programs and athletic performance
- Supporting overall metabolic health and longevity markers
- Exploring novel GH-stimulation pathways for those who respond well to peptide protocols